Does a low total IgG level make generalized immunoglobulin excess less likely without ruling out a monoclonal protein disorder?

A low total IgG in a 77-year-old man is most consistent with reduced rather than generalized immunoglobulin production or retention, but it cannot independently determine whether a clonal plasma-cell or lymphoproliferative process is present.

Clinical interpretation

• Generalized polyclonal immunoglobulin excess typically produces a broad gamma-region elevation on serum protein electrophoresis (SPEP) and often elevated IgG; an IgG concentration >20 g/L is sometimes used as a quantitative criterion after monoclonality is excluded. Low IgG therefore strongly argues against this typical generalized, IgG-predominant pattern.
• This result should be confirmed with repeat quantitative immunoglobulins, particularly if mild or unexpected. IgA and IgM should be interpreted alongside IgG, with clinical review of infections, medications, and comorbidities.

Monoclonal-protein assessment

• Low total IgG does not reliably exclude a small, oligosecretory, or light-chain monoclonal clone. Total IgG does not measure serum free light chains and may not characterize a narrow monoclonal band.
• When clinical suspicion exists, the appropriate serum screen combines SPEP, serum immunofixation, and serum free-light-chain testing. In an untreated cohort, detection was 94.3% with SPEP plus free-light-chain testing, 97.4% after adding serum immunofixation, and 98.6% with a comprehensive serum-and-urine strategy. Urine immunofixation is additionally relevant when AL amyloidosis is suspected.
• Immunoparesis—suppression of uninvolved immunoglobulins—can coexist with myeloma, reinforcing that immunoglobulin reduction does not preclude plasma-cell disease.

Mechanistic and practical considerations

• Secondary hypogammaglobulinemia can result from renal or gastrointestinal protein loss; these causes merit assessment, especially with isolated low IgG.

Bottom line

• Low IgG makes generalized polyclonal immunoglobulin excess unlikely, but it is not a rule-out test for monoclonal protein disorders; repeat immunoglobulins and targeted SPEP/immunofixation/free-light-chain testing are needed when clinically indicated.